Clinical Pharmacist Involved in the Treatment of Pneumocystis carinii Pneumonia: A Case Report
Throughout treatment, the clinical pharmacist played a vital role in optimizing the treatment plan based on the serum, urine and sputum concentrations of TMP/SMZ and providing pharmaceutical care to ensure a safe, rational and effective medications in children. Individualized dose adjustments, particularly high-dose TMP/SMZ guided by TDM, can significantly enhance the management of PCP in pediatric patients and support clinical pharmacists in delivering individualized pharmaceutical care.
Authors
- Zhongqiang Cao (ORCID: https://orcid.org/0009-0007-1703-5161)
- Wei Li (ORCID: https://orcid.org/0000-0002-7511-901X)
- Yuhui Wu (ORCID: https://orcid.org/0000-0002-2147-3857)
- Xuejuan Li (ORCID: https://orcid.org/0000-0003-4086-6063)
- Xiuqiong Huang
- Fangyuan Lai
- Jiao Peng (ORCID: https://orcid.org/0000-0002-8119-8893)
- Zebin Chen
- Nannan He (ORCID: https://orcid.org/0000-0001-7648-3131)
Institutions
- Peking University Shenzhen Hospital (CN)
- Shenzhen Children's Hospital (CN)
- The First People's Hospital of Zhaoqing (CN)
- Shenzhen Third People’s Hospital (CN)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2024-11-01
- DOI
- https://doi.org/10.2147/idr.s477404
- Primary Topic
- Pneumocystis jirovecii pneumonia detection and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00